ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Cesium carbonate → 1-(6-(5-(6-isopropoxypyrazin-2-yl)-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-amine

HRID 1529261
ノート
印刷プレビュー

反応式

HRID 1529261 の反応式
C(=O)([O-])[O-].[Cs+].[Cs+].[CH:7]([O:10][C:11]1[CH:16]=[N:15][CH:14]=[C:13](B2OC(C)(C)C(C)(C)O2)[N:12]=1)([CH3:9])[CH3:8].Br[C:27]1[CH:28]=[C:29]2[C:33](=[CH:34][CH:35]=1)[N:32](C1CCCCO1)[N:31]=[C:30]2[C:42]1[N:47]=[C:46]([N:48]2[CH2:53][CH2:52][CH:51]([NH:54]C(=O)OC(C)(C)C)[CH2:50][CH2:49]2)[CH:45]=[N:44][CH:43]=1>[Cu]I.C1(P(C2C=CC=CC=2)[C-]2C=CC=C2)C=CC=CC=1.[C-]1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=C1.[Fe+2].C([O-])(=O)C.[Pd+2].C([O-])(=O)C>[CH:7]([O:10][C:11]1[N:12]=[C:13]([C:27]2[CH:28]=[C:29]3[C:33](=[CH:34][CH:35]=2)[NH:32][N:31]=[C:30]3[C:42]2[N:47]=[C:46]([N:48]3[CH2:49][CH2:50][CH:51]([NH2:54])[CH2:52][CH2:53]3)[CH:45]=[N:44][CH:43]=2)[CH:14]=[N:15][CH:16]=1)([CH3:8])[CH3:9]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

7

反応物 3

HCID 10796Cesium carbonateHCID 457862332-Isopropoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazineHCID 67959723tert-butyl 1-(6-(5-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-ylcarbamate2 回

生成物 1

HCID 679596291-(6-(5-(6-isopropoxypyrazin-2-yl)-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-amine

試薬・触媒・溶媒 3

HCID 24350
Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)
触媒
HCID 167845palladium(II) acetate触媒
HCID 635956Ferrocene-1,1'-bis-(diphenylphosphine)触媒

反応条件

温度
80 °C

実験手順

A mixture of CuI (Aldrich, 26.6 mg, 0.27 mmol), cesium carbonate (Aldrich, 351 mg, 1.08 mmol), 1,1′-bis(diphenylphosphino)ferrocene (14.9 mg, 0.03 mmol), palladium(II) acetate (Strem Chemicals, 3.0 mg, 0.01 mmol), 2-isopropoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine (Combi-Phos, 142 mg, 0.54 mmol), and tert-butyl 1-(6-(5-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-ylcarbamate (compound 1e, 150 mg, 0.27 mmol) in a 5 mL conical microwave vial was sealed, evacuated and back-filled with N2 3×. DMF (2.7 mL) was added, and the reaction mixture was stirred at 80° C. for 16 h. The resulting reaction mixture was cooled to RT, filtered, and concentrated to dryness. The crude product was purified by HPLC (5 to 80% 0.1% TFA:Water:0.1% TFA:ACN over 25 min). The fractions were combined, washed with sat. aq. NaHCO3 and extracted with 20% IPA in chloroform. The combined organics were dried over Na2SO4, filtered, and concentrated under reduced pressure to a tan oil. The oil was dissolved in MeOH/DCM before adding 6 N HCl in IPA and stirring at 80° C. for 2 h. The reaction mixture was concentrated under reduced pressure before resolubilizing with MeOH and passing through a MeOH washed plug of Si-propylsulfonic acid. The compound was released with 2M NH3 in MeOH (30 mL) to afford 1-(6-(5-(6-isopropoxypyrazin-2-yl)-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-amine as a dark tan solid. MS (ESI, pos. ion) m/z: 431 (M+1).

後処理

  1. customwas sealed
  2. customevacuated
  3. additionback-filled with N2 3×
  4. additionDMF (2.7 mL) was added
  5. customThe resulting reaction mixture
  6. temperaturewas cooled to RT
  7. filtrationfiltered
  8. concentrationconcentrated to dryness
  9. customThe crude product was purified by HPLC (5 to 80% 0.1% TFA:Water:0.1% TFA:ACN over 25 min)
  10. washwashed with sat. aq. NaHCO3
  11. extractionextracted with 20% IPA in chloroform
  12. dry with materialThe combined organics were dried over Na2SO4
  13. filtrationfiltered
  14. concentrationconcentrated under reduced pressure to a tan oil
  15. dissolutionThe oil was dissolved in MeOH/DCM
  16. additionbefore adding 6 N HCl in IPA
  17. stirringstirring at 80° C. for 2 h
  18. concentrationThe reaction mixture was concentrated under reduced pressure

出典と根拠

ORDレコード
ord-0fdcc7d2316d4df6be21c40b0766f6d7
出典データセット
uspto-grants-2015_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09090593B2

反応ノート

読み込み中…

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート